Analysis of Efficacy and Predictive Factors for Treatment Response of Thalidomide-Containing Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Prior Chemotherapy Including Bortezomib and Lenalidomide
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要